Home › Funds › Soleus Capital Management, L.P. › ORGO

Soleus Capital Management, L.P. position in ORGO

ORGANOGENESIS HLDGS INC · Health Care

Soleus Capital Management, L.P. reported holding 10,140,951 shares of ORGO (ORGANOGENESIS HLDGS INC) in its Q2 2026 13F filing — a position valued at US$24.6M, representing 0.85% of its reported portfolio and ranking #33 among its reported holdings. Soleus Capital Management, L.P. has disclosed ORGO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)10.14M sh
Reported value held$24.64M
Portfolio Weight0.85%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s ORGO position evolved

Soleus Capital Management, L.P. first disclosed a stake in ORGO in Q3 2023 at 12,296,163 shares (US$39.1M). The position peaked in Q1 2025 at 12,478,351 shares, worth US$53.9M. Across 12 filings, Soleus Capital Management, L.P. increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 10,140,951 shares valued at US$24.6M — an increase of 55,000 shares quarter over quarter.. Notable position changes include a 27% trim in Q4 2023 (shares fell 31% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.30M $39.10M New
Q4 2023 8.96M $36.66M Reduce
Q1 2024 9.57M $27.19M Add
Q2 2024 11.52M $32.25M Add
Q3 2024 11.84M $33.86M Add
Q4 2024 12.48M $39.95M Add
Q1 2025 12.48M $53.91M Hold
Q2 2025 12.34M $45.18M Reduce
Q3 2025 12.13M $51.20M Reduce
Q4 2025 9.99M $51.73M Reduce
Q1 2026 10.09M $23.90M Add
Q2 2026 10.14M $24.64M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORGO and 13F data

ORGO (ORGANOGENESIS HLDGS INC) is a Health Care company. 25 other funds we track also report a position in ORGO. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORGO

No other tracked fund reports a position in ORGO.

All ORGO fund holders →

FAQ

How long has Soleus Capital Management, L.P. held ORGO?

Soleus Capital Management, L.P. has disclosed ORGO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Soleus Capital Management, L.P.'s current position in ORGO?

As of Q2 2026, Soleus Capital Management, L.P. holds 10.14M shares of ORGO (ORGANOGENESIS HLDGS INC), valued at $24.64M, representing 0.85% of its reported portfolio and ranking #33.

Has Soleus Capital Management, L.P. been buying or selling ORGO?

In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. increased its position in ORGO. The position peaked in Q1 2025 at 12.48M shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.